A Multi-Center, Double-Blind, Randomized, Parallel-Group Study to Evaluate Cycle Control and Safety of 6 Different Regimens of an Oral Contraceptive Containing Estradiol and Drospirenone in Healthy Female Volunteers Aged Between 18 and 35 Years Over 7 Cycles.

Trial Profile

A Multi-Center, Double-Blind, Randomized, Parallel-Group Study to Evaluate Cycle Control and Safety of 6 Different Regimens of an Oral Contraceptive Containing Estradiol and Drospirenone in Healthy Female Volunteers Aged Between 18 and 35 Years Over 7 Cycles.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Apr 2015

At a glance

  • Drugs Estradiol/drospirenone (Primary)
  • Indications Pregnancy
  • Focus Adverse reactions
  • Sponsors Bayer
  • Most Recent Events

    • 06 May 2012 New source identified and integrated (European Clinical Trials Database record EudraCT2007-005258-22).
    • 06 May 2012 Planned number of patients changed from 575 to 600 as reported by European Clinical Trials Database record.
    • 26 Jun 2009 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top